Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.
暂无分享,去创建一个
Christian Gilissen | Alexander Hoischen | Maartje van de Vorst | A. Hoischen | L. Kiemeney | J. Veltman | C. Gilissen | S. Vermeulen | M. Steehouwer | Joris A Veltman | Sita H Vermeulen | Rocio Acuna-Hidalgo | Hilal Sengul | Marloes Steehouwer | Lambertus A L M Kiemeney | Hilal Sengul | M. van de Vorst | R. Acuna-Hidalgo
[1] L. Kiemeney,et al. Cohort Profile Cohort Profile : The Nijmegen Biomedical Study ( NBS ) , 2017 .
[2] J. DeGregori,et al. Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations , 2015, Proceedings of the National Academy of Sciences.
[3] Erika J. Thompson,et al. Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control study , 2016, The Lancet. Oncology.
[4] A. Hoischen,et al. Reliable Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue Using Single Molecule Tags. , 2016, The Journal of molecular diagnostics : JMD.
[5] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[6] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[7] Subhajyoti De,et al. The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection , 2016, Nucleic acids research.
[8] G. McVean,et al. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors , 2009, Nature Genetics.
[9] Marcel J T Reinders,et al. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis , 2014, Genome research.
[10] E. Giannoulatou,et al. Visualizing the origins of selfish de novo mutations in individual seminiferous tubules of human testes , 2016, Proceedings of the National Academy of Sciences.
[11] N. Arnheim,et al. Positive Selection for New Disease Mutations in the Human Germline: Evidence from the Heritable Cancer Syndrome Multiple Endocrine Neoplasia Type 2B , 2012, PLoS genetics.
[12] K. Rauen,et al. Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome , 2011, Clinical genetics.
[13] B. Ebert,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.
[14] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[15] J. McPherson,et al. Coming of age: ten years of next-generation sequencing technologies , 2016, Nature Reviews Genetics.
[16] Jay Shendure,et al. Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation , 2013, Genome research.
[17] G. McVean,et al. Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline , 2013, Proceedings of the National Academy of Sciences.
[18] K. Rudolph,et al. Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer , 2015, Cell stem cell.
[19] Beryl B. Cummings,et al. Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring–Opitz Syndrome , 2017, Human mutation.
[20] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[21] H. Geiger,et al. Aging of hematopoietic stem cells: DNA damage and mutations? , 2016, Experimental hematology.
[22] G. Vassiliou,et al. Aging as a driver of leukemogenesis , 2015, Science Translational Medicine.
[23] M. Kubota,et al. Acute myeloid leukemia‐associated DNMT3A p.Arg882His mutation in a patient with Tatton‐Brown–Rahman overgrowth syndrome as a constitutional mutation , 2017, American journal of medical genetics. Part A.
[24] Zev N. Kronenberg,et al. Age-related mutations and chronic myelomonocytic leukemia , 2016, Leukemia.
[25] A. Hoischen,et al. Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas , 2016, Human mutation.
[26] Margaret A. Goodell,et al. DNMT3A in haematological malignancies , 2015, Nature Reviews Cancer.
[27] M. Walter,et al. ‘CHIP’ping away at clonal hematopoiesis , 2016, Leukemia.
[28] F. Lo‐Coco,et al. Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia. , 2015, The Journal of molecular diagnostics : JMD.
[29] M. Loh,et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia , 2010, Nature Genetics.
[30] D. Moore,et al. The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. , 1995, Mutation research.
[31] H. Geiger,et al. The ageing haematopoietic stem cell compartment , 2013, Nature Reviews Immunology.
[32] A. Wilkie,et al. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. , 2012, American journal of human genetics.
[33] Joshua C Randall,et al. Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation: The Deciphering Developmental Disorders Study , 2016, bioRxiv.
[34] Bradley P. Coe,et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.
[35] Joshua F. McMichael,et al. Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.
[36] L. Vissers,et al. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome , 2011, Nature Genetics.
[37] D. Grimwade,et al. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. , 2016, Blood.
[38] R. Majeti,et al. Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis , 2014, Leukemia.
[39] F. Real,et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome , 2012, Nature Genetics.
[40] K. Keeshan,et al. Insights into cell ontogeny, age, and acute myeloid leukemia. , 2015, Experimental hematology.
[41] Alexander Hoischen,et al. Prioritization of neurodevelopmental disease genes by discovery of new mutations , 2014, Nature Neuroscience.
[42] Pingfang Liu,et al. DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification , 2017, Science.
[43] I. Screpanti,et al. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype. , 2010, American journal of human genetics.
[44] I. Weissman,et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion , 2010, Proceedings of the National Academy of Sciences.
[45] M. Stratton,et al. Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.
[46] N. Arnheim,et al. Age-dependent germline mosaicism of the most common noonan syndrome mutation shows the signature of germline selection. , 2013, American journal of human genetics.
[47] Alejandro Sifrim,et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.
[48] Akash Kumar,et al. MIPgen: optimized modeling and design of molecular inversion probes for targeted resequencing , 2014, Bioinform..
[49] L. Vissers,et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.
[50] Brian T. Naughton,et al. Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases , 2016, Nature Biotechnology.
[51] T. Druley,et al. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults , 2016, Nature Communications.
[52] Christopher A. Miller,et al. The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.
[53] J. Shendure,et al. BRCA Testing by Single-Molecule Molecular Inversion Probes. , 2017, Clinical chemistry.
[54] H. Geiger,et al. Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells. , 2016, Trends in molecular medicine.
[55] R. Hennekam,et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome , 2006, Nature Genetics.
[56] S. Itzkovitz,et al. Aging, clonal hematopoiesis and preleukemia: not just bad luck? , 2015, International Journal of Hematology.
[57] E. Zeggini,et al. Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.
[58] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[59] M. Gerstein,et al. Somatic copy-number mosaicism in human skin revealed by induced pluripotent stem cells , 2012, Nature.
[60] G. McVean,et al. Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line , 2003, Science.
[61] A. Tefferi,et al. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 , 2010, Leukemia.
[62] R. Foà,et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. , 2006, American journal of human genetics.
[63] G. Sella,et al. Interpreting the Dependence of Mutation Rates on Age and Time , 2015, PLoS biology.
[64] M. Stratton,et al. The cancer genome , 2009, Nature.